Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Schoettler M 

PROVIDER: S-EPMC7988479 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature